Cyp7B1 Gene Hereditary Spastic Paraplegia 5 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
CYP7B1 (Cytochrome P450 Family 7 Subfamily B Member 1) encodes the enzyme oxysterol 7-alpha-hydroxylase, a crucial enzyme in cholesterol metabolism and bile acid synthesis [1]. Located on chromosome 8q12.3, mutations in CYP7B1 cause autosomal recessive hereditary spastic paraplegia type 5 (SPG5) and a form of congenital bile acid deficiency [2][3].
The enzyme catalyzes multiple hydroxylation reactions essential for cholesterol homeostasis:
7-alpha hydroxylation of cholesterol: First step in classic bile acid synthesis pathway
25-hydroxycholesterol metabolism: Important for oxysterol homeostasis
27-hydroxycholesterol metabolism: Key intermediate in alternative bile acid pathway
Function
Enzymatic Activity
CYP7B1 catalyzes the following reactions:
Cholesterol to 7-alpha-hydroxycholesterol: Rate-limiting step in bile acid synthesis
25-hydroxycholesterol to 7-alpha,25-dihydroxycholesterol: Oxysterol metabolism
27-hydroxycholesterol to 7-alpha,27-dihydroxycholesterol: Alternative pathway
Tissue Distribution
Liver: Primary site of expression, bile acid synthesis
Brain: [Neurons](/entities/neurons) and [astrocytes](/entities/astrocytes), neurosteroid metabolism
Kidney: Steroid hormone metabolism
Testis: Testosterone metabolism
Spinal Cord: Motor neuron expression
Physiological Roles
Bile Acid Synthesis: Essential for converting cholesterol to bile acids
The study of Cyp7B1 Gene Hereditary Spastic Paraplegia 5 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.